Herpes zoster vaccine live: A 10 year review of post-marketing safety experience

BACKGROUND: Zoster vaccine is a single dose live, attenuated vaccine (ZVL) indicated for individuals ≥50 years-old for the prevention of herpes zoster (HZ). Safety data from clinical trials and post-licensure studies provided reassurance that ZVL is generally safe and well tolerated. The objective o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Willis, English D., Woodward, Meredith, Brown, Elizabeth, Popmihajlov, Zoran, Saddier, Patricia, Annunziato, Paula W., Halsey, Neal A., Gershon, Anne A.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739308/
https://ncbi.nlm.nih.gov/pubmed/29174682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.11.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars